Treatment of Bleeding Diathesis Associated with a Heparin-Like Anticoagulant in Plasma Cell Neoplasia Using Protamine

The development of a heparin-like anticoagulant (HLAC) in plasma cell neoplasia has previously been described in clinical literature. Testing of this HLAC, primarily in vitro, has demonstrated that neutralization may be achieved with protamine sulfate, owing to antithrombin III cofactor activity. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Willner, Christopher A., Chisti, Mohammed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020506/
https://www.ncbi.nlm.nih.gov/pubmed/30009062
http://dx.doi.org/10.1155/2018/4342301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020506/
https://www.ncbi.nlm.nih.gov/pubmed/30009062
http://dx.doi.org/10.1155/2018/4342301

Ejemplares similares